New nasal spray aims to calm public speaking jitters in social anxiety
NCT ID NCT06809179
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 29 times
Summary
This study tests a nasal spray called fasedienol (PH94B) for quickly reducing anxiety during a public speaking task in adults aged 18-65 with social anxiety disorder. About 60 participants will be randomly assigned to receive the spray or a placebo, and those who complete the initial phase can join an open-label extension using the spray as needed for up to 12 months. The goal is to see if the spray is safe and effective for acute symptom relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOCIAL ANXIETY DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vistagen Clinical Site
RECRUITINGSherman Oaks, California, 91403, United States
-
Vistagen Clinical Site
RECRUITINGWalnut Creek, California, 94596, United States
-
Vistagen Clinical Site
RECRUITINGLargo, Florida, 33777, United States
-
Vistagen Clinical Site
RECRUITINGSaint Charles, Missouri, 63304, United States
-
Vistagen Clinical Site
RECRUITINGToms River, New Jersey, 08755, United States
-
Vistagen Clinical Site
RECRUITINGCary, North Carolina, 27511, United States
-
Vistagen Clinical Site
TERMINATEDCleveland, Ohio, 44130, United States
-
Vistagen Clinical Site
RECRUITINGPlymouth Meeting, Pennsylvania, 19462, United States
-
Vistagen Clinical Site
TERMINATEDPlano, Texas, 75093, United States
Conditions
Explore the condition pages connected to this study.